The second UK Interdisciplinary Breast Cancer Symposium was held on Monday 27th and Tuesday 28th January 2020.

The meeting provided all those with an active interest in breast cancer research and treatment an opportunity to consider and discuss how the latest advances may impact upon their and others areas of expertise. Treatment of breast cancer has for many years been dependent on the interaction of professionals from many disciplines. Research into improving our understanding of this complex disease and prospects for improving its prevention and treatment requires interdisciplinary collaboration to make meaningful advances.  The meeting included national and international keynote speakers, plenary sessions, oral and poster presentations.

The Organising Committee

Keynote Speakers

Professor David Cameron

Professor David Cameron

Edinburgh University Cancer Centre

Dr Judy Garber

Susan F. Smith Chair, Dana-Farber Cancer Institute Chief, Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute Professor of Medicine, Harvard Medical School

Dr Martine Piccart

Honorary Professor of Oncology at the Université Libre de Bruxelles (ULB) and Scientific Director at the Jules Bordet Institute (Brussels/Belgium)

Dr Monica Morrow

Chief, Breast Service, Anne Burnett Windfohr Chair of Clinical Oncology Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Professor of Surgery Weill Medical College of Cornell University, USA
Dr Matthew Ellis

Dr Matthew Ellis

Director, Lester and Sue Smith Breast Centre, Baylor College Medicine, Professor of Medicine and Cellular and Molecular Biology, Houston, Texas, USA
Dr Philip Poortmans

Dr Philip Poortmans

Radiation Oncologist & Head of Department of Radiation Oncology, Marie Curie Professor Paris Science & Lettres, Institut Curie, Paris, France

Professor Eric Winer

Professor of Medicine, Harvard Medical School; Chief, Division of Breast Oncology, and the Thompson Chair in Breast Cancer Research, Dana-Farber Cancer Institute